Wednesday, February 15, 2012

Cancer Vaccine Could See Light In 2017

Vaxil BioTherapeutics, a biotechnical company based in Ness Ziona, near Tel Aviv, Israel has produced a ground-breaking therapeutic vaccine for cancer patients which could prevent about 90 percent of cancers from coming back.

Vaxil was founded in 2006 by Dr. Lior Carmon and the vaccine is now in clinical trials at the Hadassah University Medical Centre in Jerusalem. The vaccine could be available as early as 2017 to administer on a regular basis, not only to help treat cancer but in order to keep the disease from recurring.


No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...